After five years at the reins, Mike Taylor will step down from his role as president and chief executive officer of Waltham, Mass.-based Deciphera Pharmaceuticals. Taylor’s last day in the role will by March 18, the company announced late Monday. Steve Hoerter, the chief commercial officer of Agios Pharmaceuticals, will take over the top spot of Deciphera. Hoerter has been serving as a member of the company’s board of directors. Taylor will assist Hoerter through the transition for a...
READ MORE
|
Shares of Agios Pharmaceutical shed 12 percent Monday amid concern about the safety of one of the molecules in its drug to treat pyruvate kinase deficiency, a rare, genetic anemia. The company reported that one patient saw a serious adverse event after the data collection cut-off. This patient experienced drug-related cholestatic hepatitis after a 300 mg dose. Agios said it is examining this event further…...
CNBC
READ MORE
|